How is the Graphite Bio Inc today?

The Graphite Bio Inc today is trading in the down by -0.62% at 28.82.

How has Graphite Bio Inc performed historically?

The Graphite Bio Inc is currently trading down -0.62% on an intraday basis in the past week the index fell -9.82%. The index has been up 7.50% in the past quarter and rose 7.50% in the past year. You can view this in the overview section.

What is Graphite Bio Inc Annual Net Profit?

Graphite Bio Inc Annual Net Profit fell 23.35% in the last year to $124.65 M. Its sector's average net profit growth for the last fiscal year was -14.01%.

What is Graphite Bio Inc Price to Earning Ratio?

Graphite Bio Inc Price to Earning Ratio is -13.46, which is negative.

What is Graphite Bio Inc Stock Price?

Graphite Bio Inc Stock Price rose 7.5% and underperformed its sector by 3.42% in the past year.

What is Graphite Bio Inc Quarterly Net profit?

Graphite Bio Inc Quarterly Net profit rose 6.83% YoY to $22.92 M. Its sector's average net profit growth YoY for the quarter was -236.8%.

What is Graphite Bio Inc Debt to Equity Ratio?

Graphite Bio Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Graphite Bio Inc Return on Equity(ROE)?

Graphite Bio Inc Return on Equity(ROE) for the last financial year was -51.95%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Graphite Bio Inc Mutual Fund Holding?

Graphite Bio Inc Mutual Fund Holding increased by 0.15% in the last quarter to 9.53.

What is Graphite Bio Inc Institutional Holding?

Graphite Bio Inc Institutional Holding increased by 3.74% in the last quarter to 56.24.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
GRAPHITE BIO INC

Graphite Bio Inc XNAS: GRPH

Graphite Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Graphite Bio Inc: Is Infosys Ltd. worth buying?
Item: Graphite Bio Inc
Rating: 0.60666675
Author: Trendlyne DVM scores

about

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...

28.82 -0.18 (-0.62%)

New 52W High in past week

186.6K

XNAS Volume

XNAS 16 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

2.7 / 100

Technically Bearish

21.6 / 100

No estimates available

Graphite Bio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Graphite Bio Inc Live Share Price Today, Share Analysis and Chart

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...

New 52W High in past week

SWOT Analysis

Graphite Bio Inc Live Price Chart

Graphite Bio Inc FAQ

How is Graphite Bio Inc today?

Graphite Bio Inc today is trading in the red, and is down by -0.62% at 28.82.

How has Graphite Bio Inc performed historically?

Graphite Bio Inc is currently trading down -0.62% on an intraday basis. In the past week the stock fell -9.82%. stock has been up 7.50% in the past quarter and rose 7.50% in the past year. You can view this in the overview section.